Variant report
Variant | esv3325002 |
---|---|
Chromosome Location | chr13:49532151-49537699 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FNDC3A-2 | chr13:49536817-49537104 | NONHSAT033726 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000102531 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187072575 | chr13:49532153-49532154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565339770 | chr13:49532188-49532189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535803189 | chr13:49532190-49532191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554456039 | chr13:49532192-49532193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575900745 | chr13:49532201-49532202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191069395 | chr13:49532203-49532204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143313920 | chr13:49532210-49532211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs578085652 | chr13:49532211-49532212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182970836 | chr13:49532212-49532213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187556890 | chr13:49532231-49532232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs146216495 | chr13:49532282-49532283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6561489 | chr13:49532446-49532447 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs193295343 | chr13:49532494-49532495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541175504 | chr13:49532505-49532506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs148416392 | chr13:49532518-49532519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs142626948 | chr13:49532523-49532524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567119953 | chr13:49532557-49532558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532692385 | chr13:49532601-49532602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547182263 | chr13:49532619-49532620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565399194 | chr13:49532683-49532684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185550620 | chr13:49532701-49532702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530049758 | chr13:49532784-49532785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547760610 | chr13:49532820-49532821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569656839 | chr13:49532886-49532887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs61950681 | chr13:49532893-49532894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs74075836 | chr13:49532900-49532901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs558769892 | chr13:49532904-49532905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369226707 | chr13:49532940-49532941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs9535119 | chr13:49532972-49532973 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs534785737 | chr13:49532995-49532996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs374100626 | chr13:49533030-49533031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs376951383 | chr13:49533032-49533033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572552222 | chr13:49533065-49533066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs377053340 | chr13:49533079-49533080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs562664623 | chr13:49533103-49533104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116352684 | chr13:49533160-49533161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs369908649 | chr13:49533176-49533177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs33945289 | chr13:49533196-49533197 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs187688859 | chr13:49533224-49533225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs532611390 | chr13:49533285-49533286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12561433 | chr13:49533333-49533334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528190996 | chr13:49533341-49533342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374482961 | chr13:49533342-49533343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs541584849 | chr13:49533357-49533358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559048519 | chr13:49533367-49533368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs386770840 | chr13:49533375-49533376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192184214 | chr13:49533410-49533411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184390024 | chr13:49533485-49533486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188753636 | chr13:49533499-49533500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs569313886 | chr13:49533542-49533543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Mental retardation | 17502991 | CNVD |
Retinoblastoma | 17502991 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Liposarcoma | 21253554 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cervical cancer | 21062161 | CNVD |
microdeletion syndrome | 19284877 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Breast cancer | 21858162 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hereditary prostate cancer | 22028916 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Prostate cancer | 17217626 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:49531800-49532800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
2 | chr13:49532000-49532800 | Enhancers | Muscle Satellite Cultured Cells | -- |
3 | chr13:49532800-49535200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
4 | chr13:49535200-49536200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
5 | chr13:49535400-49536000 | Enhancers | Primary monocytes fromperipheralblood | blood |
6 | chr13:49536400-49536800 | Enhancers | K562 | blood |